1. Professionally responsible management of the ethical and social challenges of antenatal screening and diagnosis of β-thalassemia in a high-risk population.
- Author
-
Corda V, Murgia F, Dessolis F, Murru S, Chervenak FA, McCullough LB, and Monni G
- Subjects
- Directive Counseling ethics, Female, Fetal Therapies ethics, Fetal Therapies methods, Genetic Testing ethics, Humans, Italy, Patient Participation, Pregnancy, Prenatal Diagnosis methods, Risk, Socioeconomic Factors, beta-Thalassemia genetics, beta-Thalassemia therapy, Patient Acceptance of Health Care, Prenatal Diagnosis ethics, Professional-Patient Relations ethics, Social Determinants of Health, beta-Thalassemia diagnosis
- Abstract
Thalassemias are among the most frequent genetic disorders worldwide. They are an important social and economic strain in high-risk populations. The benefit of β-thalassemia screening programs is growing evident but the capacity to diagnose fetal β-thalassemia exceeds the treatment possibilities and even when treatment before birth becomes feasible, difficult decisions about the relative risks will remain. This paper can be of practical and ethically justified aid when counseling women about screening, diagnosis, and treatment of β-thalassemia. It takes in consideration various social challenges, medical issues such as antenatal screening, preimplantation genetic diagnosis, prenatal diagnosis, non-invasive prenatal testing and prenatal therapy. We also describe the Sardinian experience in applying and promoting high-risk population screening and diagnosis programs and future trends in the management of β-thalassemia., (© 2021 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2021
- Full Text
- View/download PDF